Cortical lesion load associates with progression of disability in multiple sclerosis

Brain

Volumn 135, Issue 10, 2012, Pages 2952-2961

  Calabrese, Massimiliano ^a   Poretto, Valentina ^a   Favaretto, Alice ^a   Alessio, Sara ^a   Bernardi, Valentina ^a   Romualdi, Chiara ^b   Rinaldi, Francesca ^a   Perini, Paola ^a   Gallo, Paolo ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

cortical lesions; disability progression; double inversion recovery; MRI; multiple sclerosis

Indexed keywords

ADULT; AGE; ARTICLE; BRAIN CORTEX LESION; CHILD; COGNITION; DISABILITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; GRAY MATTER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SCHOOL CHILD; WHITE MATTER LESION;

EID: 84867712909     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws246     Document Type: Article

References (37)

1. Absinta M, Rocca MA, Moiola L, Copetti M, Milani N, Falini A, et al. Cortical lesions in children with multiple sclerosis. Neurology 2011; 76: 910-13.
2. Agosta F, Rovaris M, Pagani E, Sormani MP, Comi G, Filippi M. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain 2006; 129: 2620-7.
3. Amato MP, Portaccio E, Goretti B, Zipoli V, Ricchiuti L, De Caro MF, et al. The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population. Mult Scler 2006; 12: 787-93.
4. Calabrese M, Atzori M, Bernardi V, Morra A, Romualdi C, Rinaldi L, et al. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 2007a; 254: 1212-20.
5. Calabrese M, De Stefano N, Atzori M, Bernardi V, Mattisi I, Barachino L, et al. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol 2007b; 64: 1416-22.
6. Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009a; 66: 1144-50.
7. Calabrese M, Filippi M, Rovaris M, Bernardi V, Atzori M, Mattisi I, et al. Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study. Mult Scler 2009b; 15: 36-41.
8. Calabrese M, Gallo P. Magnetic resonance evidence of cortical onset of multiple sclerosis. Mult Scler 2009; 15: 933-41.
9. Calabrese M, Rocca MA, Atzori M, Mattisi I, Bernardi V, Favaretto A, et al. Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study. Neurology 2009c; 72: 1330-36.
10. Calabrese M, Rocca MA, Atzori M, Mattisi I, Favaretto A, Perini P, et al. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Ann Neurology 2010; 67: 376-83.
11. Calabrese M, Grossi P, Favaretto A, Romualdi C, Atzori M, Rinaldi F, et al. Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study. J Neurol Neurosurg Psychiatry 2012; 83: 49-54.
12. Camp SJ, Stevenson VL, Thompson AJ, Miller DH, Borras C, Auriacombe S, et al. Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. Brain 1999; 122: 1341-8.
13. Chard DT, Parker GJ, Griffin CM, Thompson AJ, Miller DH. The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology. J Magn Reson Imaging 2002; 15: 259-67.
14. Dalla Libera D, Di Mitri D, Bergami A, Centonze D, Gasperini C, Grasso MG, et al. T regulatory cells are markers of disease activity in multiple sclerosis patients. PLoS One 2011; 6: e21386.
15. De Stefano N, Matthews PM, Filippi M, Agosta F, De Luca M, Bartolozzi ML, et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003; 60: 1157-62.
16. Geurts JJ, BöL, Pouwels PJ, Castelijns JA, Polman CH, Barkhof F, et al. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 2005; 26: 572-7.
17. Geurts JJ, Roosendaal SD, Calabrese M, Ciccarelli O, Agosta F, Chard DT, et al. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology 2011; 76: 418-24.
18. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T, et al. Cortical lesions in multiple sclerosis. Brain 1999; 122: 17-26.
19. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
20. Mark J, Goldberg MA. Multiple regression analysis and mass assessment: a review of the issues. Appraisal J 2001; 89-109.
21. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-7.
22. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ, et al. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 1991; 54: 683-8.
23. Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002; 125: 1676-95.
24. Nelson F, Poonawalla AH, Hou P, Huang F, Wolinsky JS, Narayana PA. Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. AJNR Am J Neuroradiol 2007; 28: 1645-9.
25. Nelson F, Poonawalla A, Hou P, Wolinsky JS, Narayana PA. 3D MPRAGE improves classification of cortical lesions in multiple sclerosis. Mult Scler 2008; 14: 1214-19.
26. Nelson F, Datta S, Garcia N, Rozario NL, Perez F, Cutter G, et al. Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis. Mult Scler 2011; 17: 1122-9.
27. Peterson JW, Bo L, Mork S, Chang A, Trapp BD. Transected neurites, apoptotic neurons and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001; 50: 389-400.
28. Pham DL, Xu C, Prince JL. Current methods in medical image segmentation. Annu Rev Biomed Eng 2000; 2: 315-37.
29. Popescu BF, Bunyan RF, Parisi JE, Ransohoff RM, Lucchinetti CF. A case of multiple sclerosis presenting with inflammatory cortical demyelination. Neurology 2011; 76: 1705-10.
30. Ramasamy DP, Benedict R, Cox JL, Fritz D, Abdelrahman N, Hussein S, et al. Extent of cerebellum, subcortical and cortical atrophy in patients with MS A case-control study. J Neurol Sci 2009; 282: 47-54.
31. Rao SM. in collaboration with Cognitive Function Study Group of the National Multiple Sclerosis Society. A manual for the brief repeatable battery of neuropsychological tests in multiple sclerosis. Milwaukee: Medical College of Wisconsin, 1990.
32. Roosendaal SD, Hulst HE, Vrenken H, Feenstra HE, Castelijns JA, Pouwels PJ, et al. Structural and functional hippocampal changes in multiple sclerosis patients with intact memory function. Radiology 2010; 255: 595-604.
33. Roosendaal SD, Bendfeldt K, Vrenken H, Polman CH, Borgwardt S, Radue EW, et al. Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Mult Scler 2011; 17: 1098-106.
34. Rovaris M, Judica E, Gallo A, Benedetti B, Sormani MP, Caputo D, et al. Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. Brain 2006; 129: 2628-34.
35. Seewann A, Kooi EJ, Roosendaal SD, et al. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology 2012; 78: 302-8.
36. Seewann A, Vrenken H, Kooi EJ, van der Valk P, Knol DL, Polman CH, et al. Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis. Mult Scler 2011; 17: 1202-10.
37. Tur C, Khaleeli Z, Ciccarelli O, Altmann DR, Cercignani M, Miller DH, et al. Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS. J Neurol Neurosurg Psychiatry 2011; 82: 423-8.